FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000634530> ?p ?o ?g. }

• W2000634530 endingPage "459" @default.
• W2000634530 startingPage "441" @default.
• W2000634530 abstract "Assays to simultaneously detect multiple potential agents of bioterrorism are limited. Two multiplex PCR and RT-PCR enzyme hybridization assays (mPCR-EHA, mRT-PCR-EHA) were developed to simultaneously detect many of the CDC category A bioterrorism agents. The Bio T DNA assay was developed to detect: Variola major (VM), Bacillus anthracis (BA), Yersinia pestis (YP), Francisella tularensis (FT) and Varicella zoster virus (VZV). The Bio T RNA assay (mRT-PCR-EHA) was developed to detect: Ebola virus (Ebola), Lassa fever virus (Lassa), Rift Valley fever (RVF), Hantavirus Sin Nombre species (HSN) and dengue virus (serotypes 1-4). Sensitivity and specificity of the 2 assays were tested by using genomic DNA, recombinant plasmid positive controls, RNA transcripts controls, surrogate (spiked) clinical samples and common respiratory pathogens. The analytical sensitivity (limit of detection (LOD)) of the DNA asssay for genomic DNA was 1x10(0)~1x10(2) copies/mL for BA, FT and YP. The LOD for VZV whole organism was 1x10(-2) TCID(50)/mL. The LOD for recombinant controls ranged from 1x10(2)~1x10(3)copies/mL for BA, FT, YP and VM. The RNA assay demonstrated LOD for RNA transcript controls of 1x10(4)~1x10(6) copies/mL without extraction and 1x10(5)~1x10(6) copies/mL with extraction for Ebola, RVF, Lassa and HSN. The LOD for dengue whole organisms was ~1x10(-4) dilution for dengue 1 and 2, 1x10(4) LD(50)/mL and 1x10(2) LD(50)/mL for dengue 3 and 4. The LOD without extraction for recombinant plasmid DNA controls was ~1x10(3) copies/mL (1.5 input copies/reaction) for Ebola, RVF, Lassa and HSN. No cross-reactivity of primers and probes used in both assays was detected with common respiratory pathogens or between targeted analytes. Clinical sensitivity was estimated using 264 surrogate clinical samples tested with the BioT DNA assay and 549 samples tested with the BioT RNA assay. The clinical specificity is 99.6% and 99.8% for BioT DNA assay and BioT RNA assay, respectively. The surrogate sensitivities of these two assays were 100% (95%CI 83-100) for FT, BA (pX02), YP, VM, VZV, dengue 2,3,4 and 95% (95%CI 75-100) for BA (pX01) and dengue 1 using spiked clinical specimens. The specificity of both BioT multiplex assays on spiked specimens was 100% (95% CI 99-100). Compared to other available assays (culture, serology, PCR, etc.) both the BioT DNA mPCR-EHA and BioT RNA mRT-PCR-EHA are rapid, sensitive and specific assays for detecting many category A Bioterrorism agents using a standard thermocycler." @default.
• W2000634530 created "2016-06-24" @default.
• W2000634530 creator A5019514200 @default.
• W2000634530 creator A5032790993 @default.
• W2000634530 creator A5040215906 @default.
• W2000634530 creator A5044462362 @default.
• W2000634530 creator A5050347793 @default.
• W2000634530 creator A5055893792 @default.
• W2000634530 creator A5056168900 @default.
• W2000634530 creator A5068902955 @default.
• W2000634530 creator A5069392473 @default.
• W2000634530 date "2009-10-20" @default.
• W2000634530 modified "2023-10-07" @default.
• W2000634530 title "Simultaneous Detection of CDC Category A DNA and RNA Bioterrorism Agents by Use of Multiplex PCR & RT-PCR Enzyme Hybridization Assays" @default.
• W2000634530 cites W1521644402 @default.
• W2000634530 cites W1548638618 @default.
• W2000634530 cites W1715027443 @default.
• W2000634530 cites W1840588602 @default.
• W2000634530 cites W1964435848 @default.
• W2000634530 cites W1966161268 @default.
• W2000634530 cites W1973383321 @default.
• W2000634530 cites W1980355905 @default.
• W2000634530 cites W1981981071 @default.
• W2000634530 cites W2000576539 @default.
• W2000634530 cites W2000971599 @default.
• W2000634530 cites W2008396396 @default.
• W2000634530 cites W2014490977 @default.
• W2000634530 cites W2040905494 @default.
• W2000634530 cites W2041108429 @default.
• W2000634530 cites W2042646334 @default.
• W2000634530 cites W2045689375 @default.
• W2000634530 cites W2050814329 @default.
• W2000634530 cites W2066129825 @default.
• W2000634530 cites W2085138327 @default.
• W2000634530 cites W2086188951 @default.
• W2000634530 cites W2096396659 @default.
• W2000634530 cites W2098871421 @default.
• W2000634530 cites W2099094941 @default.
• W2000634530 cites W2101263138 @default.
• W2000634530 cites W2105077075 @default.
• W2000634530 cites W2105269713 @default.
• W2000634530 cites W2107922358 @default.
• W2000634530 cites W2112414534 @default.
• W2000634530 cites W2122178457 @default.
• W2000634530 cites W2124990542 @default.
• W2000634530 cites W2132870408 @default.
• W2000634530 cites W2137889830 @default.
• W2000634530 cites W2152570341 @default.
• W2000634530 cites W4235353622 @default.
• W2000634530 cites W4253090165 @default.
• W2000634530 cites W5911326 @default.
• W2000634530 doi "https://doi.org/10.3390/v1030441" @default.
• W2000634530 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2836126" @default.
• W2000634530 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20224751" @default.
• W2000634530 hasPublicationYear "2009" @default.
• W2000634530 type Work @default.
• W2000634530 sameAs 2000634530 @default.
• W2000634530 citedByCount "31" @default.
• W2000634530 countsByYear W20006345302012 @default.
• W2000634530 countsByYear W20006345302013 @default.
• W2000634530 countsByYear W20006345302014 @default.
• W2000634530 countsByYear W20006345302015 @default.
• W2000634530 countsByYear W20006345302016 @default.
• W2000634530 countsByYear W20006345302017 @default.
• W2000634530 countsByYear W20006345302019 @default.
• W2000634530 countsByYear W20006345302020 @default.
• W2000634530 countsByYear W20006345302021 @default.
• W2000634530 countsByYear W20006345302022 @default.
• W2000634530 countsByYear W20006345302023 @default.
• W2000634530 crossrefType "journal-article" @default.
• W2000634530 hasAuthorship W2000634530A5019514200 @default.
• W2000634530 hasAuthorship W2000634530A5032790993 @default.
• W2000634530 hasAuthorship W2000634530A5040215906 @default.
• W2000634530 hasAuthorship W2000634530A5044462362 @default.
• W2000634530 hasAuthorship W2000634530A5050347793 @default.
• W2000634530 hasAuthorship W2000634530A5055893792 @default.
• W2000634530 hasAuthorship W2000634530A5056168900 @default.
• W2000634530 hasAuthorship W2000634530A5068902955 @default.
• W2000634530 hasAuthorship W2000634530A5069392473 @default.
• W2000634530 hasBestOaLocation W20006345301 @default.
• W2000634530 hasConcept C104317684 @default.
• W2000634530 hasConcept C153911025 @default.
• W2000634530 hasConcept C159047783 @default.
• W2000634530 hasConcept C2779635636 @default.
• W2000634530 hasConcept C2781188995 @default.
• W2000634530 hasConcept C49105822 @default.
• W2000634530 hasConcept C533803919 @default.
• W2000634530 hasConcept C54355233 @default.
• W2000634530 hasConcept C78063203 @default.
• W2000634530 hasConcept C86803240 @default.
• W2000634530 hasConcept C89423630 @default.
• W2000634530 hasConceptScore W2000634530C104317684 @default.
• W2000634530 hasConceptScore W2000634530C153911025 @default.
• W2000634530 hasConceptScore W2000634530C159047783 @default.
• W2000634530 hasConceptScore W2000634530C2779635636 @default.
• W2000634530 hasConceptScore W2000634530C2781188995 @default.
• W2000634530 hasConceptScore W2000634530C49105822 @default.
• W2000634530 hasConceptScore W2000634530C533803919 @default.

• next